FIELD: pharmaceutics.
SUBSTANCE: invention relates to the field of pharmaceutics, namely to cholestyramine pellets, which can be obtained by molding. Pellets have high cholestyramine load and are sufficiently stable for the application of a shell of one or more shell layers. The invention also relates to a method for the production of such pellets and to a system for the delivery of particles of a drug, including such pellets.
EFFECT: pellets are suitable for oral administration, and they can be used for the treatment of hypercholesterolemia, hyperlipoproteinemia type II and diabetes mellitus type 2.
18 cl, 2 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ORAL CHOLESTYRAMINE COMPOSITION AND APPLICATION THEREOF | 2017 |
|
RU2750937C2 |
| ORAL CHOLESTYRAMINE COMPOSITION AND APPLICATION THEREOF | 2017 |
|
RU2750944C2 |
| CHOLESTYRAMINE PELLETS, ORAL CHOLESTYRAMINE COMPOSITIONS AND THEIR USE | 2018 |
|
RU2782016C2 |
| COATING COMPOSITION SUITABLE FOR PHARMACEUTICAL OR NUTRICEUTICAL DOSAGE FORMS | 2011 |
|
RU2606588C2 |
| PHARMACEUTICAL FORM FOR DRUG DELIVERY TO THE COLON | 2007 |
|
RU2646825C2 |
| DRUG FORM FOR DELIVERY OF MEDICATION INTO LARGE INTESTINE | 2007 |
|
RU2478372C2 |
| PERORAL PHARMACEUTICAL COMPOSITIONS OF MESALAZINE | 2017 |
|
RU2744576C2 |
| ORAL PHARMACEUTICAL COMPOSITIONS OF NICOTINAMIDE | 2017 |
|
RU2738114C2 |
| LIQUID PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION BASED ON AMINOSALICYLATES | 2019 |
|
RU2804487C2 |
| MEDICINAL RETARD-FORMULATION CONTAINING TRAMADOL SACCHARINATE | 2000 |
|
RU2292877C2 |
